Royce & Associates LP increased its holdings in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 11.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 585,526 shares of the health services provider’s stock after purchasing an additional 58,508 shares during the period. Royce & Associates LP’s holdings in Maximus were worth $31,144,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Nisa Investment Advisors LLC increased its holdings in Maximus by 0.6% in the third quarter. Nisa Investment Advisors LLC now owns 31,919 shares of the health services provider’s stock worth $1,698,000 after purchasing an additional 195 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Maximus by 60.8% during the 3rd quarter. Allworth Financial LP now owns 645 shares of the health services provider’s stock worth $35,000 after buying an additional 244 shares in the last quarter. Root Financial Partners LLC bought a new position in shares of Maximus during the 3rd quarter worth approximately $26,000. Covestor Ltd boosted its holdings in shares of Maximus by 33.2% during the 3rd quarter. Covestor Ltd now owns 2,199 shares of the health services provider’s stock worth $117,000 after buying an additional 548 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Maximus by 33.1% during the 2nd quarter. GAMMA Investing LLC now owns 2,306 shares of the health services provider’s stock worth $124,000 after buying an additional 574 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.
Maximus Stock Down 0.0%
Shares of MMS traded down $0.01 during trading hours on Friday, hitting $64.86. The stock had a trading volume of 449,081 shares, compared to its average volume of 587,204. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The firm has a 50 day simple moving average of $59.47 and a 200-day simple moving average of $63.56. The firm has a market capitalization of $3.40 billion, a P/E ratio of 9.58 and a beta of 0.57. Maximus, Inc. has a 1-year low of $51.04 and a 1-year high of $100.00.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a $0.33 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.32 annualized dividend and a yield of 2.0%. Maximus’s dividend payout ratio is presently 19.50%.
Insider Transactions at Maximus
In other Maximus news, insider Michelle Link sold 3,208 shares of the stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total value of $173,969.84. Following the transaction, the insider owned 13,881 shares in the company, valued at approximately $752,766.63. This represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.80% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on MMS. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Zacks Research upgraded shares of Maximus from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 1st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Two analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock has an average rating of “Hold”.
Read Our Latest Analysis on MMS
Maximus Company Profile
Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.
Further Reading
- Five stocks we like better than Maximus
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
